Afuco™ Anti-Human ERG ADCC Therapeutic Antibody, ADCC Enhanced
Anti-ERG ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies that bind to ERG can be used to treat malignancies associated with overexpression of ERG or an ERG fusion event, such as prostate cancer, Ewing's sarcoma, acute myeloid leukemia, acute T-lymphoblastic leukemia, endothelial cancer, and colon cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-235CL |
| Pricing | Inquiry |
| Host | Human |
| Target | ERG |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |